Cargando…
Mitochondria, PPARs, and Cancer: Is Receptor-Independent Action of PPAR Agonists a Key?
Before the discovery of peroxisome proliferator activated receptors (PPARs), it was well known that certain drugs considered as classical PPAR-alpha agonists induced hepatocarcinoma or peroxisome proliferation in rodents. These drugs were derivatives of fibric acid, and they included clofibrate, bez...
Autores principales: | Scatena, Roberto, Bottoni, Patrizia, Giardina, Bruno |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2464819/ https://www.ncbi.nlm.nih.gov/pubmed/18645611 http://dx.doi.org/10.1155/2008/256251 |
Ejemplares similares
-
Mitochondrial Respiratory Complexes as Targets of Drugs: The PPAR Agonist Example
por: Bottoni, Patrizia, et al.
Publicado: (2022) -
Mitochondria, metabolism and cancer: a growing role in cancer cell differentiation and cancer cell dormancy
por: Scatena, Roberto, et al.
Publicado: (2014) -
Scaffold-Based Pan-Agonist Design for the PPARα, PPARβ and PPARγ Receptors
por: Zhang, Li-Song, et al.
Publicado: (2012) -
PPARα-Independent Arterial Smooth Muscle Relaxant Effects of PPARα Agonists
por: Silswal, Neerupma, et al.
Publicado: (2012) -
Safety of PPAR Agonists
por: Home, Philip
Publicado: (2011)